25021-246 : Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution


NDC: 25021-246
Labeler: Sagent Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Thiotepa
Dosage Form: Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution
Application #: ANDA209150
Rev. Date: 


NDC Package Codes:

  • 25021-246-02: 1 VIAL IN 1 CARTON (25021‑246‑02) > 1.5 ML IN 1 VIAL

Active Ingredients:

  • Thiotepa

Dosage Strength:

  • 15 mg/1.5mL

Pharmaceutical Classes:

  • Alkylating Activity [MoA]
  • Alkylating Drug [EPC]

Related Products:

Based on records with the same trade name.
  • 0143-9292 Thiotepa 100 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9309 Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 0143-9565 Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceutical Corp
  • 43598-171 Thiotepa 100 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Dr.reddy's Laboratories Inc.,
  • 43598-650 Thiotepa 15 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Dr.reddy's Laboratories Inc.,
  • 54879-014 Thiotepa 15 mg/15mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Sti Pharma LLC
  • 55390-030 Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 65219-029 Thiotepa 100 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 68083-446 Thiotepa 15 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Gland Pharma Limited
  • 68083-503 Thiotepa 100 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Gland Pharma Limited
  • 69539-123 Thiotepa 15 mg Intracavitary; Intravenous; Intravesical Injection, Powder, for Solution by Msn Laboratories Private Limited
  • 69539-124 Thiotepa 100 mg Intracavitary; Intravenous; Intravesical Injection, Powder, for Solution by Msn Laboratories Private Limited
  • 70860-220 Thiotepa 15 mg/1.5ml Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Athenex Pharmaceutical Division, LLC.
  • 71288-156 Thiotepa 15 mg Intracavitary; Intravenous; Intravesical Injection, Powder, for Solution by Meitheal Pharmaceuticals Inc
  • 71288-157 Thiotepa 100 mg Intracavitary; Intravenous; Intravesical Injection, Powder, for Solution by Meitheal Pharmaceuticals Inc
  • 72205-045 Thiotepa 15 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Novadoz Pharmaceuticals LLC
  • 72205-046 Thiotepa 100 mg Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Novadoz Pharmaceuticals LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 25021-246 QR Code

< Prev: 25021-245Next: 25021-247 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.